259 related articles for article (PubMed ID: 20584310)
1. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer.
Cadenas C; Franckenstein D; Schmidt M; Gehrmann M; Hermes M; Geppert B; Schormann W; Maccoux LJ; Schug M; Schumann A; Wilhelm C; Freis E; Ickstadt K; Rahnenführer J; Baumbach JI; Sickmann A; Hengstler JG
Breast Cancer Res; 2010; 12(3):R44. PubMed ID: 20584310
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence.
Lim JY; Yoon SO; Hong SW; Kim JW; Choi SH; Cho JY
World J Gastroenterol; 2012 Oct; 18(39):5581-8. PubMed ID: 23112551
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
Cho SY; Kim S; Son MJ; Rou WS; Kim SH; Eun HS; Lee BS
Dig Dis Sci; 2019 Jan; 64(1):123-136. PubMed ID: 30288659
[TBL] [Abstract][Full Text] [Related]
4. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR
Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741
[TBL] [Abstract][Full Text] [Related]
5. Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response.
Godoy P; Cadenas C; Hellwig B; Marchan R; Stewart J; Reif R; Lohr M; Gehrmann M; Rahnenführer J; Schmidt M; Hengstler JG
Breast Cancer; 2014 Jul; 21(4):491-9. PubMed ID: 23001506
[TBL] [Abstract][Full Text] [Related]
6. ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.
Petry IB; Fieber E; Schmidt M; Gehrmann M; Gebhard S; Hermes M; Schormann W; Selinski S; Freis E; Schwender H; Brulport M; Ickstadt K; Rahnenführer J; Maccoux L; West J; Kölbl H; Schuler M; Hengstler JG
Clin Cancer Res; 2010 Jan; 16(2):451-60. PubMed ID: 20068093
[TBL] [Abstract][Full Text] [Related]
7. TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma.
Fu B; Meng W; Zeng X; Zhao H; Liu W; Zhang T
Biomed Res Int; 2017; 2017():4698167. PubMed ID: 28536696
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid Upregulates Thioredoxin-interacting Protein in Cultured Neuronal Cells.
Bharti V; Tan H; Chow D; Wang Y; Nagakannan P; Eftekharpour E; Wang JF
Neuroscience; 2018 Aug; 384():375-383. PubMed ID: 29894818
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231.
Turturro F; Friday E; Welbourne T
BMC Cancer; 2007 Jun; 7():96. PubMed ID: 17555594
[TBL] [Abstract][Full Text] [Related]
10. The thioredoxin system in breast cancer cell invasion and migration.
Bhatia M; McGrath KL; Di Trapani G; Charoentong P; Shah F; King MM; Clarke FM; Tonissen KF
Redox Biol; 2016 Aug; 8():68-78. PubMed ID: 26760912
[TBL] [Abstract][Full Text] [Related]
11. Estradiol regulates the thioredoxin antioxidant system in the mouse uterus.
Deroo BJ; Hewitt SC; Peddada SD; Korach KS
Endocrinology; 2004 Dec; 145(12):5485-92. PubMed ID: 15345672
[TBL] [Abstract][Full Text] [Related]
12. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
[TBL] [Abstract][Full Text] [Related]
13. ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction.
Brase JC; Schmidt M; Fischbach T; Sültmann H; Bojar H; Koelbl H; Hellwig B; Rahnenführer J; Hengstler JG; Gehrmann MC
Clin Cancer Res; 2010 Apr; 16(8):2391-401. PubMed ID: 20371687
[TBL] [Abstract][Full Text] [Related]
14. TXNIP interaction with the Her-1/2 pathway contributes to overall survival in breast cancer.
Nie W; Huang W; Zhang W; Xu J; Song W; Wang Y; Zhu A; Luo J; Huang G; Wang Y; Guan X
Oncotarget; 2015 Feb; 6(5):3003-12. PubMed ID: 25605021
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
16. ERBB2 overexpression triggers transient high mechanoactivity of breast tumor cells.
Martin M; Müller K; Cadenas C; Hermes M; Zink M; Hengstler JG; Käs JA
Cytoskeleton (Hoboken); 2012 May; 69(5):267-77. PubMed ID: 22407943
[TBL] [Abstract][Full Text] [Related]
17. miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
Shin B; Feser R; Nault B; Hunter S; Maiti S; Ugwuagbo KC; Majumder M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430859
[TBL] [Abstract][Full Text] [Related]
18. The expression of redox proteins in phyllodes tumor.
Kim S; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):365-74. PubMed ID: 24068538
[TBL] [Abstract][Full Text] [Related]
19. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50.
Turturro F; Von Burton G; Friday E
Clin Cancer Res; 2007 Jun; 13(12):3724-30. PubMed ID: 17575238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
